| Title | Orbital inflammatory disease secondary to a single-dose administration of zoledronic acid for treatment of postmenopausal osteoporosis. | | Author(s) | Procianoy F, Procianoy E | | Institution | Department of Ophthalmology and Otolaringology, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil, procianoy@yahoo.com. | | Source | Osteoporos Int 2009 Oct 27. | | Abstract | A 60-year-old woman received a single 5-mg dose of zoledronic acid (Aclasta(R)) for treatment of postmenopausal osteoporosis. One day after receiving the drug, she acutely developed a painful periorbital swelling, chemosis, and hyperemia in the right eye. The condition worsened despite initial treatment with topical steroids. An orbital CT scan showed right eye proptosis, eyelid edema, and intraorbital fat stranding. A diagnosis of orbital inflammatory disease was made, and the patient was treated with high-dose oral steroids (prednisone 80 mg/day) tapered along 6 weeks. The symptoms and the swelling reduced progressively after initiating oral prednisone, and after 12 days, there was complete resolution of the condition. The patient remained symptom free and had no remission after the treatment interruption. | | Language | ENG | | Pub Type(s) | JOURNAL ARTICLE
| | PubMed ID | 19859646 |
|
